(772) 276-7242 Mon–Fri 9:00am–4:30pm
Online payments Patient portal Español
Stuart Oncology Associates
Personalized cancer care since 1979

Home/Cancers/Myeloproliferative neoplasms

Myeloproliferative neoplasms

Myeloproliferative neoplasms, cared for close to home by one team.

Myeloproliferative neoplasms — including polycythemia vera, essential thrombocythemia, and myelofibrosis — are chronic blood conditions in which the marrow makes too many blood cells. Our hematologists diagnose and manage them with a focus on controlling symptoms and reducing long-term risk.

How we approach it

Long-term management

These are chronic conditions; the goal is to control blood counts, ease symptoms, and lower the risk of clotting over years

Risk-based treatment

Treatment is matched to your specific type and risk — from low-dose medication to targeted therapy

Coordinated monitoring

On-site labs make the regular bloodwork these conditions require simple and close to home

What the workup looks like

1
Confirming the diagnosis

Bloodwork — and often a bone marrow biopsy and genetic testing such as JAK2 — pins down the specific type.

2
Assessing your risk

We weigh your counts, symptoms, age, and any clotting history to gauge risk and guide how intensively to treat.

3
Your ongoing plan

Most patients are managed long-term with medication and regular monitoring, explained clearly and kept close to home.

Common questions

Are myeloproliferative neoplasms a form of cancer?
They're considered chronic blood cancers, but many are slow-moving and managed successfully for years — more like a long-term condition than an acute illness.
What is the JAK2 mutation?
It's a genetic change found in many of these conditions. Testing for it helps confirm the diagnosis and guide treatment.
Why is clotting a concern?
Too many blood cells can thicken the blood and raise the risk of clots, so a major goal of treatment is reducing that risk.
Will I need chemotherapy?
Often not in the traditional sense. Treatment may be as simple as low-dose medication and, for some, targeted therapy — tailored to your type and risk.

This page is general information, not medical advice for your specific situation. Every diagnosis — and every patient — is different. Bring your questions to your care team.